| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Gen. Counsel, Corp. Sec.
1 company
Barbara A Wood last filed a Form 4 in January 2024, as EVP, Gen. Counsel, Corp. Sec. at SLS. Barbara A Wood's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 117,225 shares of SLS. The SLS filings lean toward selling, a net 3,000 shares.
Barbara A Wood has 10 Form 4 filings on record from March 2018 to January 2024, all as EVP, Gen. Counsel, Corp. Sec. at SELLAS Life Sciences Group (SLS), 2018–2024.
The 15 reported transactions were 7 option or other derivative awards, 5 stock awards, 2 open-market sales and 1 other transaction.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $11K.
The largest open-market sale was 2,153 shares of SLS at an average $2.59 on December 5, 2022, about $6K. Twelve months later SLS was down 58%.
Shares as reported in the last Form 4 for each company; the most recent is from January 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.